PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections

Name: PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections
License: Public Domain

Rambam Health Care Campus

ClinicalTrials.gov · Datasets · License: Public Domain

beta lactam resistant bacterial infection, enterobacteriaceae infections, bacteremia

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 184876
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.